A deeper understanding of osteosarcoma, the most common primary malignant bone tumor affecting children and adolescents, is reshaping strategies for overcoming treatment resistance.

Researchers have identified mutated proteins strongly linked to bone cancer by constructing a multimodal map of human ...

The Company reiterates its commitment to seeking to obtain FDA approval for OST-HER2 in the rare pediatric cancer osteosarcoma in 2025. The Company is eligible to receive a Priority Review Voucher ...

After doctors initially prescribed rest and painkillers, an MRI scan in December ... is possible.' Osteosarcoma is the most common type of bone cancer and it mostly affects children and young ...

A deeper understanding of osteosarcoma, the most common primary malignant bone tumor affecting children and adolescents, is ...